enVVeno Medical Corp. has appointed Jennifer Bright as Chief Financial Officer, effective May 19, 2025. With over 25 years of experience in financial and strategic leadership across various medical device and pharmaceutical companies, Bright will oversee the company's financial strategy and operations. She succeeds Craig Glynn, who will remain with the company in an advisory role.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. enVVeno Medical Corp. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1028083) on May 19, 2025, and is solely responsible for the information contained therein.